Zurich Cantonal Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.58M | Sell |
68,234
-46,531
| -41% | -$5.85M | 0.02% | 489 |
|
|
2025
Q1 | $12.7M | Buy |
114,765
+53,505
| +87% | +$5.92M | 0.04% | 401 |
|
|
2024
Q4 | $8.36M | Buy |
61,260
+360
| +0.6% | +$49.1K | 0.02% | 475 |
|
|
2024
Q3 | $7.02M | Sell |
60,900
-29,118
| -32% | -$3.35M | 0.02% | 497 |
|
|
2024
Q2 | $12.4M | Buy |
90,018
+26,195
| +41% | +$3.61M | 0.04% | 364 |
|
|
2024
Q1 | $8.8M | Buy |
63,823
+18,884
| +42% | +$2.6M | 0.03% | 430 |
|
|
2023
Q4 | $5.92M | Buy |
44,939
+25,245
| +128% | +$3.33M | 0.02% | 499 |
|
|
2023
Q3 | $2.22M | Sell |
19,694
-400
| -2% | -$45K | 0.01% | 679 |
|
|
2023
Q2 | $1.89M | Buy |
20,094
+5
| +0% | +$471 | 0.01% | 717 |
|
|
2023
Q1 | $2.03M | Buy |
20,089
+168
| +0.8% | +$17K | 0.01% | 682 |
|
|
2022
Q4 | $2.38M | Sell |
19,921
-785
| -4% | -$93.8K | 0.01% | 635 |
|
|
2022
Q3 | $2.2M | Buy |
20,706
+869
| +4% | +$92.3K | 0.01% | 647 |
|
|
2022
Q2 | $1.93M | Buy |
19,837
+1,752
| +10% | +$171K | 0.01% | 681 |
|
|
2022
Q1 | $1.7M | Sell |
18,085
-91
| -0.5% | -$8.53K | 0.01% | 763 |
|
|
2021
Q4 | $1.55M | Sell |
18,176
-1,957
| -10% | -$167K | 0.01% | 824 |
|
|
2021
Q3 | $1.93M | Sell |
20,133
-83
| -0.4% | -$7.96K | 0.01% | 756 |
|
|
2021
Q2 | $1.97M | Buy |
20,216
+180
| +0.9% | +$17.5K | 0.01% | 732 |
|
|
2021
Q1 | $1.95M | Buy |
20,036
+5,057
| +34% | +$492K | 0.01% | 708 |
|
|
2020
Q4 | $1.44M | Sell |
14,979
-12,240
| -45% | -$1.17M | 0.01% | 832 |
|
|
2020
Q3 | $2.62M | Buy |
27,219
+5,012
| +23% | +$482K | 0.02% | 623 |
|
|
2020
Q2 | $2.71M | Buy |
22,207
+3,238
| +17% | +$395K | 0.02% | 541 |
|
|
2020
Q1 | $1.64M | Buy |
18,969
+1,073
| +6% | +$92.9K | 0.02% | 646 |
|
|
2019
Q4 | $1.92M | Buy |
17,896
+12,153
| +212% | +$1.31M | 0.01% | 677 |
|
|
2019
Q3 | $518K | Buy |
5,743
+497
| +9% | +$44.8K | ﹤0.01% | 903 |
|
|
2019
Q2 | $443K | Hold |
5,246
| – | – | ﹤0.01% | 940 |
|
|
2019
Q1 | $462K | Sell |
5,246
-870
| -14% | -$76.6K | ﹤0.01% | 910 |
|
|
2018
Q4 | $437K | Buy |
6,116
+448
| +8% | +$32K | ﹤0.01% | 913 |
|
|
2018
Q3 | $697K | Buy |
5,668
+159
| +3% | +$19.6K | 0.01% | 853 |
|
|
2018
Q2 | $541K | Buy |
5,509
+352
| +7% | +$34.6K | ﹤0.01% | 893 |
|
|
2018
Q1 | $428K | Sell |
5,157
-747
| -13% | -$62K | ﹤0.01% | 896 |
|
|
2017
Q4 | $458K | Buy |
5,904
+1,200
| +26% | +$93.1K | ﹤0.01% | 883 |
|
|
2017
Q3 | $288K | Buy |
4,704
+1,599
| +51% | +$97.9K | ﹤0.01% | 929 |
|
|
2017
Q2 | $143K | Sell |
3,105
-1,237
| -28% | -$57K | ﹤0.01% | 1157 |
|
|
2017
Q1 | $188K | Sell |
4,342
-3,601
| -45% | -$156K | ﹤0.01% | 1023 |
|
|
2016
Q4 | $307K | Hold |
7,943
| – | – | ﹤0.01% | 905 |
|
|
2016
Q3 | $402K | Buy |
7,943
+5,547
| +232% | +$281K | ﹤0.01% | 872 |
|
|
2016
Q2 | $109K | Hold |
2,396
| – | – | ﹤0.01% | 1108 |
|
|
2016
Q1 | $95K | Hold |
2,396
| – | – | ﹤0.01% | 1161 |
|
|
2015
Q4 | $136K | Buy |
2,396
+1,294
| +117% | +$73.4K | ﹤0.01% | 1018 |
|
|
2015
Q3 | $44K | Buy |
1,102
+730
| +196% | +$29.1K | ﹤0.01% | 1157 |
|
|
2015
Q2 | $18K | Hold |
372
| – | – | ﹤0.01% | 1130 |
|
|
2015
Q1 | $15K | Buy |
+372
| New | +$15K | ﹤0.01% | 1189 |
|
|
2014
Q3 | – | Sell |
-45,000
| Closed | -$668K | – | 985 |
|
|
2014
Q2 | $668K | Hold |
45,000
| – | – | 0.02% | 654 |
|
|
2014
Q1 | $725K | Hold |
45,000
| – | – | 0.02% | 600 |
|
|
2013
Q4 | $420K | Hold |
45,000
| – | – | 0.01% | 682 |
|
|
2013
Q3 | $509K | Buy |
+45,000
| New | +$509K | 0.02% | 593 |
|